2026 NPPES data Dermatology Physician NPI 1154485811 D.O.
Verify on CMS →

SCOTT FRIEDMAN, D.O.

Dermatology Physician in RIVERVIEW, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 613 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.2K
57 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SCOTT FRIEDMAN, D.O. is a Dermatology Physician ([object Object]) practicing in RIVERVIEW, Michigan with a Medicare Part D prescribing footprint of 2K claims across 613 beneficiaries — 4% brand-name prescribing . Industry payments of $1.2K across 57 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SCOTT FRIEDMAN, D.O. filed 1,546 Medicare Part D claims in 2023 across RIVERVIEW, Michigan. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

SCOTT FRIEDMAN, D.O. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

SCOTT FRIEDMAN, D.O. at a glance

Quality data not reported

NPI registry status

Active

Issued 12/20/2006

NPI 1154485811

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,546 112% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Michigan

How Dermatology Physician compares to other specialties among Michigan providers

Michigan providers

Dermatology Physician share within Michigan

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SCOTT FRIEDMAN, D.O. is a Dermatology Physician provider practicing in RIVERVIEW, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1154485811. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SCOTT FRIEDMAN, D.O. appears in the CMS NPPES registry as a Dermatology Physician provider holding D.O. credentials at 17171 FORT ST, RIVERVIEW, MI, 48193, with a listed phone of (734) 282-7266. NPI 1154485811 was issued on 12/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FRIEDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,546 prescription claims written by this provider, covering 613 Medicare beneficiaries and totaling roughly $433K in drug spend, split 4% brand-name and 96% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

17171 FORT ST
RIVERVIEW, MI 48193

Provider Details

NPI 1154485811
Specialty Dermatology Physician
Credentials D.O.
Gender Male
NPI Issued 12/20/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SCOTT FRIEDMAN, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to SCOTT FRIEDMAN, D.O.. To verify SCOTT FRIEDMAN, D.O.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SCOTT FRIEDMAN, D.O. — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 1,546 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,546
Total Claims
$433K
Total Drug Cost
613
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,752
Total Day Supply
38,743
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$400K
Generic Drug Cost
$33K
Antibiotic Claims
485

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.23
Gender Split
49% female / 51% male
Age Distribution
<65: 58, 65-74: 288, 75-84: 199, 85+: 68

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Cephalexin
282
Ketoconazole
167
Triamcinolone Acetonide
112
Hydrocortisone
84
Betamethasone Dipropionate
54
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
52
Ammonium Lactate
51
Nystatin
50
Amoxicillin
38
Azithromycin
38

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How SCOTT FRIEDMAN, D.O. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

SCOTT FRIEDMAN, D.O.'s 1,546 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as FRIEDMAN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SCOTT FRIEDMAN, D.O.'s specialty?
SCOTT FRIEDMAN, D.O. specializes in Dermatology Physician and practices in RIVERVIEW, Michigan. Credentials: D.O..
How much does SCOTT FRIEDMAN, D.O. prescribe under Medicare Part D?
In 2023, SCOTT FRIEDMAN, D.O. wrote 1,546 Medicare Part D claims totaling $433K in drug costs for 613 beneficiaries.
Where is SCOTT FRIEDMAN, D.O. located?
SCOTT FRIEDMAN, D.O. is located at 17171 FORT ST, RIVERVIEW, MI, 48193. Phone: (734) 282-7266.
What is SCOTT FRIEDMAN, D.O.'s NPI number?
SCOTT FRIEDMAN, D.O.'s National Provider Identifier (NPI) is 1154485811, issued on 12/20/2006.
Does SCOTT FRIEDMAN, D.O. prescribe more brand-name or generic drugs?
SCOTT FRIEDMAN, D.O.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $400K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does SCOTT FRIEDMAN, D.O. prescribe most often?
Based on 2023 Medicare Part D data, SCOTT FRIEDMAN, D.O.'s most frequently prescribed drugs include Cephalexin, Ketoconazole, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SCOTT FRIEDMAN, D.O. accept Medicare?
SCOTT FRIEDMAN, D.O. appears in CMS Medicare data with 1,546 Part D claims and 613 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SCOTT FRIEDMAN, D.O.'s credentials?
SCOTT FRIEDMAN, D.O.'s NPI is 1154485811 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology